A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia

NCT00316238 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: olanzapine-RAIM
DRUG: placebo

Sponsor

Eli Lilly and Company